DELOGU, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 3.841
NA - Nord America 1.637
SA - Sud America 1.187
EU - Europa 448
AF - Africa 292
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 7.409
Nazione #
US - Stati Uniti d'America 1.544
SG - Singapore 1.464
VN - Vietnam 918
BR - Brasile 865
CN - Cina 553
HK - Hong Kong 501
ZA - Sudafrica 220
FR - Francia 187
AR - Argentina 128
IT - Italia 73
EC - Ecuador 70
IN - India 66
MX - Messico 62
BD - Bangladesh 53
ID - Indonesia 50
CO - Colombia 40
IQ - Iraq 34
DE - Germania 33
PY - Paraguay 25
RU - Federazione Russa 25
PH - Filippine 23
VE - Venezuela 23
GB - Regno Unito 22
TR - Turchia 22
MA - Marocco 17
PK - Pakistan 17
SA - Arabia Saudita 17
ES - Italia 14
TH - Thailandia 14
UA - Ucraina 14
UZ - Uzbekistan 14
CL - Cile 12
JP - Giappone 12
MY - Malesia 12
EG - Egitto 10
KE - Kenya 10
NL - Olanda 10
PE - Perù 10
PL - Polonia 9
CA - Canada 8
DZ - Algeria 8
KZ - Kazakistan 8
SE - Svezia 8
TN - Tunisia 8
TW - Taiwan 8
UY - Uruguay 8
ET - Etiopia 7
IE - Irlanda 6
LT - Lituania 6
NP - Nepal 6
OM - Oman 6
AL - Albania 5
BH - Bahrain 5
CH - Svizzera 5
KR - Corea 5
AO - Angola 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
IR - Iran 4
JO - Giordania 4
MD - Moldavia 4
NI - Nicaragua 4
PS - Palestinian Territory 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BW - Botswana 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
FI - Finlandia 3
QA - Qatar 3
RS - Serbia 3
AU - Australia 2
BE - Belgio 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
LV - Lettonia 2
MK - Macedonia 2
SN - Senegal 2
SR - Suriname 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BJ - Benin 1
BY - Bielorussia 1
CY - Cipro 1
DM - Dominica 1
GP - Guadalupe 1
KH - Cambogia 1
KW - Kuwait 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
RE - Reunion 1
Totale 7.404
Città #
Dallas 529
San Jose 501
Hong Kong 484
Singapore 432
Ho Chi Minh City 332
Hanoi 199
Johannesburg 198
Lauterbourg 176
Beijing 121
Ashburn 104
São Paulo 76
Los Angeles 57
Buffalo 46
Da Nang 43
Haiphong 31
Mexico City 31
Columbus 27
Guayaquil 24
Quito 24
Rio de Janeiro 24
Hefei 23
Munich 20
Brasília 19
Belo Horizonte 18
Biên Hòa 18
Boardman 18
Hải Dương 18
Baghdad 16
New York 16
Porto Alegre 16
Shanghai 16
Thái Nguyên 14
Can Tho 13
Curitiba 13
Fortaleza 13
Salvador 13
Tashkent 12
Thái Bình 12
Bắc Ninh 11
Rome 11
Dhaka 10
Guangzhou 10
Joinville 10
Milan 10
Tianjin 10
Casablanca 9
Hyderabad 9
Nairobi 9
Ninh Bình 9
Warsaw 9
Atlanta 8
Bangkok 8
Bogotá 8
Chennai 8
Council Bluffs 8
Jakarta 8
Jeddah 8
London 8
Orem 8
Quảng Ngãi 8
Zhengzhou 8
Asunción 7
Cuenca 7
Córdoba 7
Guarulhos 7
Ha Long 7
Monte Grande 7
Montevideo 7
Parma 7
Santo André 7
Addis Ababa 6
Bauru 6
Brooklyn 6
Buenos Aires 6
Cape Town 6
Changsha 6
Ciudad del Este 6
Dublin 6
Frankfurt am Main 6
Hortolândia 6
La Plata 6
Nuremberg 6
Phủ Lý 6
Stockholm 6
São Bernardo do Campo 6
Uberaba 6
Uberlândia 6
Campinas 5
Canoas 5
Caracas 5
Diadema 5
Istanbul 5
Jinan 5
Macaé 5
Marseille 5
Muscat 5
Piracicaba 5
Quận Bình Thạnh 5
Redondo Beach 5
Santiago 5
Totale 4.182
Nome #
Comprehensive Whole Genome Sequencing Dataset of Mycobacterium tuberculosis Strains Collected Across Italy 184
Comparative genomic analysis of bacteriocin genes in Lactobacillus crispatus strains 104
Current Evidence on the Relation Between Microbiota and Oral Cancer—The Role of Fusobacterium nucleatum—A Narrative Review 98
The activity of cell-free supernatant of Lactobacillus crispatus M247: a promising treatment against vaginal infections 91
The Potential Role of the Microbiome in the Pathogenesis of Nasal Tumors: A Comprehensive Review 87
Short-term gut microbiota’s shift after laparoscopic Roux-en-Y vs one anastomosis gastric bypass: results of a multicenter randomized control trial 79
Accuracy of p16 IHC in Classifying HPV-Driven OPSCC in Different Populations 72
Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma 72
Specific immune response to M. tuberculosis and ability to in vitro control mycobacterial replication are not impaired in subjects with immune-mediated inflammatory disease and tuberculosis infection 66
A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles 62
Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites 59
Carbon nanomaterials: a new way against tuberculosis 58
Case Report: Multifocal Tubercular Osteomyelitis of the Spine and Bilateral Dactylitis 57
The PPE domain of PPE17 is responsible for its surface localization and can be used to express heterologous proteins on the mycobacterial surface. 57
Accuracy of QuantiFERON-TB Gold-PLUS Test for the Diagnosis of Mycobacterium tuberculosis Infection in Children 56
Accuracy of QuantiFERON-TB Gold-PLUS Test for the Diagnosis of Mycobacterium tuberculosis infection in Children 55
Epidemic and pandemic viral infections: Impact on tuberculosis and the lung 55
HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region 54
Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseases 54
C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay 53
Molecular typing of Mycobacterium tuberculosis strains: A fundamental tool for tuberculosis control and elimination 52
3-(Benzodioxan-2-ylmethoxy)-2,6-difluorobenzamides bearing hydrophobic substituents at the 7-position of the benzodioxane nucleus potently inhibit methicillin-resistant Sa and Mtb cell division 52
Toll-Like Receptor 2 Mediates In Vivo Pro- and Anti-inflammatory Effects of Mycobacterium Tuberculosis and Modulates Autoimmune Encephalomyelitis 51
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children 51
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 51
ADHESIVENESS OF BACILLUS-SUBTILIS STRAINS TO EPITHELIAL-CELLS CULTURED IN-VITRO 50
Alternative therapies against Mycobacterium abscessus infections 50
HINTT working group within the GABRIEL network. (2020) Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort study 50
In vitro effect of unacylated ghrelin and obestatin on human luteal cell function 50
Functional dissection of protein domains involved in the immunomodulatory properties of PE_PGRS33 of Mycobacterium tuberculosis 50
Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection 50
HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice 50
Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy 49
Bacillus cereus keratitis associated with contact lens wear 47
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 47
Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants 46
The spectrum of tuberculosis infection: new perspectives in the era of biologics 45
PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2 45
Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy 45
Host Directed Therapies for Tuberculosis: Futures Strategies for an Ancient Disease. 45
Unraveling the Gut Microbiome–Diet Connection: Exploring the Impact of Digital Precision and Personalized Nutrition on Microbiota Composition and Host Physiology 45
Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli 44
Tuberculosis patients are characterized by a low-IFN-gamma/high-TNF-alpha response to methylated HBHA produced in M. smegmatis 44
M tuberculosis in the adjuvant modulates time of appearance of CNS-specific effector T cells in the spleen through a polymorphic site of TLR2. 43
Prospective Evaluation of Epidemiological, Clinical, and Microbiological Features of Pandemic Influenza A (H1N1) Virus Infection in Italy 43
Development of antitubercular compunds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies 43
In-Depth Immunophenotyping With Mass Cytometry During TB Treatment Reveals New T-Cell Subsets Associated With Culture Conversion 43
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 42
The biology of mycobacterium tuberculosis infection 42
Detection of Mycobacterium tuberculosis DNA in CD34+ peripheral blood mononuclear cells of adults with tuberculosis infection and disease 42
A Twenty-year Retrospective Study of Pediatric Tuberculosis in Two Tertiary Hospitals in Rome 42
Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy 42
Characterization of gut microbiota in patients with metabolic syndrome candidates for bariatric/metabolic surgery: Preliminary findings of a multi-center prospective study 42
PPE_MPTR genes are differentially expressed by Mycobacterium tuberculosis in vivo 41
Mycobacterium tuberculosis virulence: insights and impact on vaccine development 41
Accuracy of QuantiFERON-TB Gold Test for Tuberculosis Diagnosis in Children 41
Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study 41
Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences 40
Incidental intraoperative diagnosis of Mycobacterium abscessus meningeal infection: a case report and review of the literature 40
Lifestyles and ageing: targeting key mechanisms to shift the balance from unhealthy to healthy ageing 40
IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay 40
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 40
Children and COVID-19: Microbiological and immunological insights 40
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy 40
Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector 40
Suspected transmission of tuberculosis in a maternity ward from a smear-positive nurse: preliminary results of clinical evaluations and testing of neonates potentially exposed, Rome, Italy, 1 January to 28 July 2011 40
First description of agonist and antagonist IP-10 in urine of patients with active TB 40
Isolation and identification of Mycobacterium neoaurum from a patient with urinary infection 40
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection 40
3D-printed graphene polylactic acid devices resistant to SARS-CoV-2: Sunlight-mediated sterilization of additive manufactured objects 39
Understanding cutaneous tuberculosis: two clinical cases 39
Monocyte‐to‐lymphocyte, neutrophil‐to‐lymphocyte and neutrophil‐to‐monocyte plus lymphocyte ratios in children with active tuberculosis: A multicentre study 39
Mycobacterium smegmatis Expressing a Chimeric Protein MPT64-Proteolipid Protein (PLP) 139-151 Reorganizes the PLP-Specific T Cell Repertoire Favoring a CD8-Mediated Response and Induces a Relapsing Experimental Autoimmune Encephalomyelitis 39
Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children 39
Recombinant BCG-Rv1767 amount determines, in vivo, antigen-specific T cells location, frequency, and protective outcome 38
Graphene Oxide-Linezolid Combination as Potential New Anti-Tuberculosis Treatment 38
HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice 38
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection 38
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 38
The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection 38
TLR2: A CROSSROADS BETWEEN INFECTIONS AND AUTOIMMUNITY? 38
Specific T Cells Restore the Autophagic Flux Inhibited by Mycobacterium tuberculosis in Human Primary Macrophages 37
The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis 37
Vacuum-assisted closure (VAC®) systems and microbiological isolation of infected wounds 37
Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice 37
PE_PGRS proteins of Mycobacterium tuberculosis: A specialized molecular task force at the forefront of host-pathogen interaction 37
Evaluation of PE_PGRS33 as a potential surface target for humoral responses against Mycobacterium tuberculosis 37
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 37
Laser-Mediated antibacterial effects of Few- and Multi-Layer Ti3C2Tx MXenes 37
PGRS domain structures: Doomed to sail the mycomembrane 37
Secrets and lies of host-microbial interactions: MHC restriction and trans-regulation of T cell trafficking conceal the role of microbial agents on the edge between health and multifactorial/complex diseases 36
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness 36
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 36
Heparin-binding hemagglutinin HBHA from Mycobacterium tuberculosis affects actin polymerisation 36
Comparative Immune Response to a PE and PE_PGRS antigen of Mycobacterium tuberculosis 36
Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children. On Behalf Of The Gemelli-Pediatric Covid-Team 36
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. 36
Mycobacterium smegmatis expressing a chimeric protein MPT64-PLP139-151 reorganizes the PLP-specific T cell repertoire favouring a CD8-mediated response and induces a relapsing EAE1 36
PE_PGRS33, an Important Virulence Factor of Mycobacterium tuberculosis and Potential Target of Host Humoral Immune Response 35
QuantiFERON TB Gold: a new method for latent tuberculosis infection 35
Totale 4.802
Categoria #
all - tutte 20.643
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.643


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 2 0 0
2021/20224 0 0 0 0 0 1 0 0 0 0 1 2
2022/20234 1 0 0 0 0 0 0 0 3 0 0 0
2023/20241 0 0 0 0 0 0 0 0 0 0 0 1
2024/2025822 0 1 1 0 0 1 2 1 2 1 237 576
2025/20266.776 209 965 1.398 886 777 252 693 261 920 415 0 0
Totale 7.610